Doctor of Osteopathy Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Kory Johnson

Orthopaedic Surgery Grand Rapids, MI Doctor of Osteopathy

NPI 1952539603 CMS profile 224818

1111 Leffingwell Ave Ne, Grand Rapids, MI 49525

Open in the dashboard

General payments

$79,144

94 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$75,125 paid to institutions, not to them · program years 2019–2023

Through program year 2025, Kory Johnson of Grand Rapids, MI is reported in the CMS Open Payments database as having received $79,144 across 94 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $75,125 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 91st percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $9,766 9
2024 General $4,523 8
2023 General $16,011 11
2022 General $8,175 15
2021 General $16,526 26
2020 General $8,983 5
2019 General $15,159 20

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Kory Johnson
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Kory Johnson were reported at $9,766. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Kory Johnson Orthopaedic Surgery median Middle half National median
2019 $15,159 $644 $140–$2,844 $163
2020 $8,983 $312 $75–$1,860 $114
2021 $16,526 $520 $117–$2,495 $132
2022 $8,175 $598 $128–$2,731 $149
2023 $16,011 $461 $128–$2,264 $160
2024 $4,523 $497 $134–$2,475 $164
2025 $9,766 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Medical Device Business Services, Inc. $68,939 44 payments
  2. DePuy Synthes Products, Inc. $6,748 6 payments
  3. DePuy Synthes Sales Inc. $1,760 23 payments
  4. Zimmer Biomet Holdings, Inc. $1,145 10 payments
  5. Bioventus LLC $164 1 payment
  6. Sanara MedTech Inc. $111 1 payment
  7. Smith+Nephew, Inc. $62 1 payment
  8. Davol Inc. $56 2 payments
  9. Stryker Corporation $47 1 payment
  10. Boston Scientific Corporation $37 2 payments
  11. Other $75 3 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $71,334 19 payments
  2. Travel and Lodging $4,596 19 payments
  3. Food and Beverage $3,214 56 payments
Products named General payments · program years 2019–2025
  1. PINNACLE Ortho-Hip $50,375 18 payments
  2. RECLAIM Ortho-Hip $50,375 18 payments
  3. Pinnacle Gription $49,866 16 payments
  4. PINNACLE Ortho-Hip $19,109 10 payments
  5. RECLAIM Ortho-Hip $19,005 9 payments
  6. GRIPTION $18,865 8 payments
  7. Arcos $783 3 payments
  8. ATTUNE $549 9 payments
  9. Pinnacle Gription TF $508 2 payments
  10. Velys $426 4 payments
  11. Other $1,599 25 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 7 drugs

Part D claims

965

Median for Orthopedic Surgery: 203

Drug cost

$4,345

Median for Orthopedic Surgery: $1,433

Branded share of claims

0%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Meloxicam Generic 250 $1,796
Methocarbamol Generic 181 $1,151
Amoxicillin Generic 393 $665
Mupirocin Generic 45 $272
Doxycycline Hyclate Generic 11 $237
Clindamycin Hcl Generic 57 $150
Cephalexin Generic 28 $74

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 41 billing codes

Paid by Medicare

$128,210

Medicare's payments for the services billed

Medicare patients

205

Average age 72

Services billed

1,159

123 women, 82 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 74%
Ischemic heart disease 29%
Depression 27%
Diabetes 23%
Chronic kidney disease 20%
Atrial fibrillation 16%
Heart failure 15%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

94 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in Michigan

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record